Robert Peabody - Net Worth and Insider Trading

Robert Peabody Net Worth

The estimated net worth of Robert Peabody is at least $291,715 dollars as of 2024-11-10. Robert Peabody is the Sr. VP, COO, and CFO of Lineage Cell Therapeutics Inc and owns about 315,777 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $291,715. Details can be seen in Robert Peabody's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Peabody has not made any transactions after 2014-07-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert Peabody

To

Robert Peabody Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Peabody owns 3 companies in total, including Asterias Biotherapeutics Inc (AST) , Lineage Cell Therapeutics Inc (LCTX) , and Ocata Therapeutics Inc (OCAT) .

Click here to see the complete history of Robert Peabody’s form 4 insider trades.

Insider Ownership Summary of Robert Peabody

Ticker Comapny Transaction Date Type of Owner
AST Asterias Biotherapeutics Inc 2016-02-28 director
LCTX Lineage Cell Therapeutics Inc 2014-07-22 Senior VP & COO
OCAT Ocata Therapeutics Inc 2005-07-06 director & VP - Grant Administration

Robert Peabody Latest Holdings Summary

Robert Peabody currently owns a total of 1 stock. Robert Peabody owns 315,777 shares of Lineage Cell Therapeutics Inc (LCTX) as of July 22, 2014, with a value of $291,715.

Latest Holdings of Robert Peabody

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LCTX Lineage Cell Therapeutics Inc 2014-07-22 315,777 0.92 291,715

Holding Weightings of Robert Peabody


Robert Peabody Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Peabody has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the sale of 100,000 shares on July 22, 2014, which brought Robert Peabody around $265,000.

Insider Trading History of Robert Peabody

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Peabody Trading Performance

GuruFocus tracks the stock performance after each of Robert Peabody's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Peabody is 0.54%. GuruFocus also compares Robert Peabody's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Peabody within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert Peabody's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert Peabody

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 20.91 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 16.41 LIMIT LIMIT LIMIT LIMIT LIMIT

Robert Peabody Ownership Network

Ownership Network List of Robert Peabody

No Data

Ownership Network Relation of Robert Peabody

Insider Network Chart

Robert Peabody Owned Company Details

What does Asterias Biotherapeutics Inc do?

Who are the key executives at Asterias Biotherapeutics Inc?

Robert Peabody is the director of Asterias Biotherapeutics Inc. Other key executives at Asterias Biotherapeutics Inc include other: See Remarks Below Neal C Bradsher , other: See Remarks Below Broadwood Partners Lp , and other: See Remarks Below Broadwood Capital Inc .

Asterias Biotherapeutics Inc (AST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Asterias Biotherapeutics Inc (AST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Asterias Biotherapeutics Inc (AST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Asterias Biotherapeutics Inc (AST)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Asterias Biotherapeutics Inc Insider Transactions

No Available Data

Robert Peabody Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Peabody. You might contact Robert Peabody via mailing address: One Innovation Drive, Worchester Ma 01605.